Skip to main content

CorVista Health to Present New Data on Non-Invasive Point of Care Test for Ischemia with Non-Obstructive Coronary Arteries Using Machine Learning at ACC.26

CorVista Health today announced the upcoming poster presentation of new data on its non-invasive point of care test for ischemia with non-obstructive coronary arteries (INOCA) – a common condition, particularly in women, where patients experience cardiovascular symptoms despite having no flow-limiting blockages in their major epicardial arteries – using machine learning at the American College of Cardiology’s Annual Scientific Session (ACC.26), taking place March 28-30, 2026, in New Orleans, LA.

Details of the presentations are as follows:

Title: Noninvasive Ischemia Detection in Symptomatic Patients: A Physiologic Feature Machine-Learned Model

Presenters:

  • Charles Bridges, EVP and Chief Scientific Officer, CorVista Health
  • Tim Burton, Data Scientist, CorVista Health

Format: Oral Poster

Presentation Number: Poster #78

Date and Time: Monday, March 30, 2026, at 12:30 p.m. ET – 1:30 p.m. ET

Location: Section 1590 (Ischemic Heart Diseases)

CorVista Health will be exhibiting in the Future Hub Booth #FH8, where attendees can learn about the CorVista System.

About CorVista System®

The CorVista System is an FDA-cleared, non-invasive cardiovascular diagnostics platform designed to analyze cardiac and hemodynamic signals using machine-learned algorithms. The system synchronously collects physiological signals during a brief point-of-care test and applies advanced analytics to identify patterns associated with pulmonary hypertension (PH) and coronary artery disease (CAD). The CorVista System delivers actionable diagnostic insights without the use of radiation, contrast agents, injections, fasting, or exercise. The CorVista System is developed and manufactured by Analytics For Life, Inc. and licensed to CorVista Health, Inc.

About CorVista Health

CorVista Health is dedicated to transforming cardiovascular care through innovative diagnostics that shorten the path from symptoms to diagnosis. By enabling earlier detection of complex cardiovascular conditions, CorVista aims to empower clinicians with actionable insights and improve patient outcomes across diverse care settings.

For more information on CorVista Health, please visit: www.corvista.com

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.95
-2.19 (-1.04%)
AAPL  253.72
+2.22 (0.88%)
AMD  202.40
-0.28 (-0.14%)
BAC  48.21
+0.69 (1.45%)
GOOG  291.11
-7.91 (-2.65%)
META  595.57
-8.49 (-1.41%)
MSFT  373.71
-9.29 (-2.43%)
NVDA  175.23
-0.41 (-0.23%)
ORCL  148.41
-5.93 (-3.84%)
TSLA  383.12
+2.27 (0.60%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.